Senior Accountant

    Boston, US
470 Atlantic Avenue, 14th Floor
MA 02210 Boston
Vereinigte Staaten

Company Background

MorphoSys is focused on creating significant value for all of its stakeholders through a strategy that balances short- and long-term growth potential. By applying its proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies. The company has established successful and lasting partnerships with industry-leading companies from the pharmaceutical and biotechnology sectors. The product pipeline, one of the broadest in the antibody industry, proves the sustainable quality of MorphoSys' work. Through specific in-licensing and co-development activities, the company is adding higher value programs to the pipeline at a significant rate. Their comprehensive partnering strategy is an important feature of their business model and a vital source of MorphoSys' financial strength.
 
2018 was an important year for MorphoSys. The company took a large step toward their goal of becoming a fully integrated biopharmaceutical company.

Tafasitamab (MOR208) is an investigational Fc-engineered therapeutic antibody targeting CD19 that is in development for the treatment of B cell malignancies. The focus of the development program is on relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a particularly aggressive form of lymphoma, for which there are no approved treatments. Tafasitamab received breakthrough therapy designation (BTD) from the FDA in 2017 based on preliminary data from the phase 2 L-MIND study, which is evaluating the safety and efficacy of Tafasitamab in combination with lenalidomide. MorphoSys has publicly disclosed the final study data in May 2019, which will be presented at ICML and be used to support the BLA filing scheduled at the end of 2019.

To advance the development of Tafasitamab and in preparation for its planned subsequent commercialization, MorphoSys has founded MorphoSys US Inc., a wholly owned subsidiary of MorphoSys AG. An additional important step in order to increase the U.S. footprint was the successful closing of an IPO on the Nasdaq U.S. stock exchange in April 2018.

Job Summary

We are looking for a highly motivated individual with a minimum of 5 years of accounting experience, knowledge of SOX control, and IFRS.  The position reports directly to the Controller, works closely with the SVP of Finance and other key stakeholders in the US business, and the finance team located in Company Headquarters in Germany.

As a member of the finance team, you will be accountable for the accounting and SOX activities for MorphoSys US. The Senior Accountant will maintain general ledger integrity, ensure timely financial closing, assist external auditor review, manage & process vendor invoices and payment. In addition, the Senior Accountant will significantly contribute to the overall control environment by providing training and proactive accounting guidance to our Business Partners and internal stakeholders and keeping all Standard Operating Procedures (SOPs) current. This individual will also help to drive continuous improvement initiatives aimed at increasing the efficiency of our processes as well as supporting transformational activities. The Senior Accountant must possess great attention to detail and ability to learn new things, as the responsibilities will expand as we grow to inventory, revenue recognition and accounts receivable. Detailed responsibilities as below:

Key Accountabilities
  • Responsible for all aspects of closing activates by preparing assigned journal entries, account reconciliations and conducting BS and P&L variance analysis.
  • Conducts end to end of supplier invoicing and payment process to ensure our vendors and employees are paid on time.
  • Maintains fixed asset register to ensure fixed assets are properly capitalized and depreciated in accordance with useful life.
  • Assists external auditor PwC review and SOX control documentation.
  • Act as subject matter expert for SAP by Design.
  • Conducts accounting research for new accounting standards.
  • Contributes to excellence in execution and continuous improvement of accounting processes and controls.
  • Performs various analysis and Ad Hoc reports as required.

Job Qualifications, Experience & Skills

Required
  • A minimum of a Bachelor's degree in Accounting.
  • A minimum of 3 years of experience in accounting is required.
  • Ability to work in a fast-paced environment and manage well through ambiguity and complexity.
  • Previously SOX documentation experience is required.
  • Strong knowledge of SAP and advanced skills in MS office.
Preferred
  • CPA is preferred.
  • Previous experience in Public Accounting is preferred.  
  • Knowledge of IFRS and understanding of lease accounting IFRS16 are preferred.
  • Previous accounts payable experience is preferred.
  • Demonstrates strong time management and organizational skills.
  • Strong communication skills, a collaborative working style, and the ability to work effectively with others in a team-oriented environment is required.
  • Exhibits strong problem solving, analytical skills, and a comfort level with asking questions or challenge the status quo.

Location
  • Boston, MA
Ähnliche Stellenanzeigen um Vereinigte Staaten
Lade...